Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Silvia Enriquez Calzada

Silvia Enriquez Calzada

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca
Silvia Enriquez Calzada

Silvia Enriquez Calzada

Silvia Enriquez Calzada

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Related news

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Infermera i pacient de Parkinson amb teràpia subcutània

A new therapeutic strategy improves the control of motor symptoms in Parkinson's disease

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Pacient amb Parkinson i alumnes de 4t d'ESO jugant a escacs

Vall d'Hebron begins a citizen science project with adolescents and Parkinson's patients

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

See more

Related professionals

Arantxa Ibarz Casas

Arantxa Ibarz Casas

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more
Maria Pallares Masmitja

Maria Pallares Masmitja

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Josep Masramon Puig

Josep Masramon Puig

Research technician
Rheumatology
Read more
Silvia Soler García

Silvia Soler García

Research technician
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.